Blog Elements – Page 8 – AxxcessWealth

Half Sized Blog Element (Single Author Style)

Half Sized Blog Element (Multi Author Style)

Human Genomics Investing: Where Healthcare Meets Technology

There is a revolution happening that will help you and others live longer, better lives. Your medical care will be more personalized, your medication more potent and precise, and we will finally be able to conquer world hunger. This is not a political or social revolution, but a scientific one. The genomic revolution has begun […]

May 10, 2018/by Kevin Manzo

ARK Wins Two ETF.com Awards

Kevin Manzo

As your advisor I am constantly researching ways to grow your money. You won’t see me hosting seminars or steak dinners. I started in the wealth management business from the portfolio management side, so I know how the sauce is made. I am always focused on ways to adapt and innovate for my clients. Former […]

April 18, 2018/by Kevin Manzo

Human Genomics Investing: Where Healthcare Meets Technology

Kevin Manzo, Themes- Innovation

May 10, 2018/by Kevin Manzo

ARK Wins Two ETF.com Awards

Kevin Manzo

April 18, 2018/by Kevin Manzo

Full Sized Blog Element (Big Preview Pic)

Human Genomics Investing: Where Healthcare Meets Technology

Kevin Manzo, Themes- Innovation

The genomic revolution has begun and is picking up steam. Already, scientists can sequence the entire human genome, over 20,000 genes, in only a few days and at a cost of only $1,000. Medical care can get truly personal when doctors have access to an actual map of your genes. No longer will care be reactive, but rather proactive and preventive.

This genomic knowledge will also lead to better pharmaceutical developments. Drugs will become more powerful, precise, and profitable — something we will all benefit from.

Beyond just DNA, a greater understanding of proteins, RNA, microbiomes, and other molecules will impact diagnostics and treatments. Stem cells will play an instrumental role in pharmaceuticals and therapy. The genomic revolution is turning the medical world upside down.

Genomic sequencing goes beyond just humans, though. Bacteria, cancer, cantaloupes, and cats can all be sequenced to give us a better understanding of how life thrives, grows, and heals. Not only will human life be transformed in this revolution, but agriculture will as well. Genetically modified crops will become safer and more cost-efficient, bolstering the world’s food supply.

The genomic revolution is providing deeper biological insights and innovations that advance safety and efficacy across the board. The increasingly powerful analytics are eliminating guesswork in everything from genetics to crop planting. Genomic sequencing is revolutionizing the medical industry, and you can be a part of it.

You don’t have to be a scientist or medical doctor to join the revolution that is extending and enhancing the quality of human life. As an investor, you can play a major role as well. You can invest in companies that incorporate technological and scientific developments, improvements, and advancements in genomics into their business.

Not only will investing in human genomics put you on the forefront of a revolution, it can also be very profitable. According to research, genomic sequencing of DNA is expected to grow at a 200% annual growth rate. If you want to be a part of revolutionizing health care, agriculture, and pharmaceuticals through your investments, call us today at 858.217.5347.

About Kevin

Kevin Manzo is a Financial Advisor with Axxcess Wealth Management. Kevin’s services are especially valuable to business owners, high-income and high-net-worth professionals and their families. After 12 successful years as a portfolio manager and advisor Kevin has the knowledge and experience to help clients protect what they’ve worked for, enjoy a comfortable retirement, and leave the legacy they choose for their heirs. Along with his Bachelor’s of Business Administration degree in Finance from Chapman University, he also holds the Accredited Investment Fiduciary® credential, signifying his commitment to upholding a high level of fiduciary care for his clients. Based in Fullerton, California, he serves families and business owners throughout North Orange County and Los Angeles. Learn more by connecting with Kevin on LinkedIn.

May 10, 2018/by Kevin Manzo

ARK Wins Two ETF.com Awards

Kevin Manzo

Innovation is constant in our society and I wanted to add it to portfolios. I researched ways to add exposure to client accounts with this specific theme of innovation. I came across a management team at www.arkinvest.com that was a perfect fit for what I wanted. Here I found a strategy I could add to client portfolios that was focused on today’s disruptive innovative technologies: robotics, automation, 3D printing, human genomics, Crypto Currency, and artificial intelligence to name a few.

I am proud to announce that the ARK Innovation ETF has been named ETF of the Year as well as being named the Most Innovative ETF Issuer of the Year at the fifth annual ETF.com Awards.

About ARK Innovation

ARK is an actively managed fund focused on capturing the performance of companies involved in “disruptive innovation.” The fund was up an astonishing 87% last year, partially due to it’s allocation to the Bitcoin Investment Trust and the “FANG” stocks, otherwise known as Facebook, Apple, Netflix, and Google/Alphabet. In fact, it was one of our top holdings at Axxcess this past year. The company is driven to capitalize on rapid change in our society and avoid industries and companies likely to be displaced by technological innovation.

If you want to learn more about ARK and its values and vision, check out the full article. If you have any questions about our investment strategy or about how we work to bring growth to your portfolio, contact our office today by calling 858.217.5347.

About Kevin

April 18, 2018/by Kevin Manzo

Important Information

Advisory services provided by Axxcess Wealth Management, LLC (AWM), an Investment Adviser registered with the SEC. Advisory services are only offered to clients or prospective clients where Axxcess Wealth Management, LLC and its Investment Advisor Representatives are properly licensed or exempt from registration.

For complete disclosures please visit:

Half Sized Blog Element (Single Author Style)

Half Sized Blog Element (Multi Author Style)

Human Genomics Investing: Where Healthcare Meets Technology

ARK Wins Two ETF.com Awards

Human Genomics Investing: Where Healthcare Meets Technology

ARK Wins Two ETF.com Awards

Full Sized Blog Element (Big Preview Pic)

Human Genomics Investing: Where Healthcare Meets Technology

About Kevin

ARK Wins Two ETF.com Awards

About ARK Innovation

About Kevin

Contact Us

Quick Links

Important Information

Find Us